Lenz Therapeutics, Inc. · NASDAQ:LENZ
Point72 Asset Management, L.P.'s stake in Lenz Therapeutics, Inc. fell to 4.80% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Point72 Asset Management, L.P.'s stake in Lenz Therapeutics, Inc. fell to 4.80%, 1,357,751 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 4.80%
- Shares
- 1,357,751
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 1.20% | 340,000 |
| Point72 Capital Advisors, Inc. | 1.20% | 340,000 |
| Point72 Biotech Private Investments, LLC | 3.60% | 1,017,751 |
| Differentiated Ventures Investments, LLC | 3.60% | 1,017,751 |
| 72 Investment Holdings, LLC | 3.60% | 1,017,751 |
| Steven A. Cohen | 4.80% | 1,357,751 |
Source
Related
- Lenz Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Lenz Therapeutics, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Oct 21, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Schedule 13G · Millennium Management LLC · Jun 26, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G · Squarepoint Ops LLC · Apr 8, 2026